| ARCHETYPE ID | openEHR-EHR-CLUSTER.microscopy_renal_biopsy_non_neoplastic.v0 |
|---|---|
| Concept | Microscopy renal biopsy non neoplastic |
| Description | Microscopic findings related to a non-neoplastic renal biopsy |
| Use | To record detailed findings about microscopic examination of tissue related to glomerular, tubulointerstitial and vascular renal diseases. Use as a component archetype in the context of a suite of archetypes that make up a histopathology report i.e. OBSERVATION.lab_test.histopathology |
| Misuse | Not designed to be used within any other archetype other than OBSERVATION.lab_test.histopathology. |
| Purpose | To record detailed findings about a non-neoplastic renal biopsy |
| References | Chang A, Gibson IW, Cohen AH, Weening JW, Jennette JC, and Fogo AB (2012). A position paper on standardizing the nonneoplastic kidney biopsy report. Hum Pathol 43:1192-1196. Farris AB, Adams CD, Brousaides N, Della Pelle PA, Collins AB, Moradi E, Smith RN, Grimm PC, and Colvin RB (2011). Morphometric and visual evaluation of fibrosis in renal biopsies. J Am Soc Nephrol 22:176-186. Berden AE, Ferrario F, Hagen EC, Jayne DR, Jennette JC, Joh K, Neumann I, Noel LH, Pusey CD, Waldherr R, Bruijn JA, and Bajema IM (2010). Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628-1636. Koss MN. Handling and interpretation of the medical renal biopsy (2014). Methods Mol Biol; 1180: 323-336 Racusen LC, Solez K, Colvin RB et al. The Banff 97 working classification of renal allograft pathology. Kidney International 1999; 55: 713-723 Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. American Journal of Transplantation 2008; 8: 753-760 Jennette JC, D'Agati VD, Olson JL, Silva F. Heptinstall's Pathology of the Kidney. LWW, Philadelphia: 2014; Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, Balow JE, Bruijn JA, Cook T, Ferrario F, Fogo AB, Ginzler EM, Hebert L, Hill G, Hill P, Jennette JC, Kong NC, Lesavre P, Lockshin M, Looi LM, Makino H, Moura LA, Nagata M. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 Feb;15(2):241-50. Erratum in: J Am Soc Nephrol. 2004 Mar;15(3):835-6. Working Group of the International IgA Nephropathy Network and the Renal Pathology Society, Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, Coppo R, D'Agati V, D'Amico G, Emancipator S, Emma F, Feehally J, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int. 2009 Sep;76(5):546-56. |
| Copyright | © Nasjonal IKT HF |
| Authors | Author name: Sabine Leh Organisation: Haukeland University Hospital Email: sabine.leh@helse-bergen.no Date originally authored: 2014-06-08 |
| Other Details Language | Author name: Sabine Leh Organisation: Haukeland University Hospital Email: sabine.leh@helse-bergen.no Date originally authored: 2014-06-08 |
| Other Details (Language Independent) |
|
| Keywords | histopathology, pathology, renal, laboratory |
| Lifecycle | in_development |
| UID | 324df9ac-fdc6-4e36-ae8f-b78755354d87 |
| Language used | en |
| Citeable Identifier | 1246.145.2596 |
| Revision Number | 0.0.1-alpha |
| items | |
| Renal biopsy overall description | Renal biopsy overall description: Describes tissue types in the renal biopsy specimen. |
| Cortex | Cortex: Cortical tissue present, alternatively core length with cortical tissue, alternatively proportion of cortical tissue in relation to the core with renal tissue. Choice of:
|
| Medulla | Medulla: Medullary tissue present, alternatively core length with medullary tissue, alternatively proportion of medullary tissue in relation to the core with renal tissue. Choice of:
|
| Renale capsule | Renale capsule: A statement whether the renal capsule is present. |
| Other tissue elements | Other tissue elements: Description of other tissue elements, e.g. muscle tissue. Choice of:
|
| Glomeruli | Glomeruli: Description of glomerular changes. |
| Glomeruli | Glomeruli: The maximum number of glomeruli irrespective of size present in one section; structures consisting of Bowman's capsule with empty Bowman's space are excluded. |
| Scorable glomeruli | Scorable glomeruli: The number of glomeruli judged as adequate for scoring by the reporting pathologist. |
| Glomeruli solely with necrosis | Glomeruli solely with necrosis: The number of glomeruli showing fibrinoid necrosis without crescent formation. |
| Glomeruli with crescents | Glomeruli with crescents: The number of glomeruli showing cellular or fibrocellular crescents. |
| Glomeruli with ischemic changes | Glomeruli with ischemic changes: The number of glomeruli showing some degree of tuft retraction and wrinkling of capillary walls. Chronic ischemic changes might show fibrosis of Bowman's capsule. |
| Glomeruli with adhesions | Glomeruli with adhesions: The number of glomeruli showing coneective tissue connections between the tuft and Bowman's capsule without overt sclerosis. |
| Glomeruli with segmental sclerosis | Glomeruli with segmental sclerosis: The number of glomeruli showing obliteration of capillary lumen by extracellular matrix in a portion of the tuft area with or without adhesions to the Bowman capsule, hyaline lesions, foam cells. |
| Glomeruli with global sclerosis | Glomeruli with global sclerosis: The number of glomeruli showing scarring with obliteration of capillary lumen by extracellular matrix in the entire or nearly entire glomerular tuft. |
| Normal glomeruli | Normal glomeruli: The number of glomeruli which appear normal without major changes. |
| Mesangium | Mesangium: Description of mesangial changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the mesangial areas. |
| Details of the mesangium | Details of the mesangium: A narrative description of mesangial changes. |
| Mesangial matrix increase | Mesangial matrix increase: Visual assessment of the amount of mesangial matrix. Choice of:
|
| Mesangial hypercellularity | Mesangial hypercellularity: A visual assessment of the cellularity of the mesangium. Normally there are 1 - 3 cells per mesangial area. The score is based on the most cellular mesangial area. Mesangial areas adjacent to the vascular stalk should not be scored. Definitions based on Roberts et al, 2009. Choice of:
|
| Mesangial nodularity | Mesangial nodularity: A visual assessment of the presence of acellular PAS positive mesangial nodules. Choice of:
|
| Capillaries | Capillaries: Description of glomerular capillary changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of the glomerular capillaries. |
| Details of glomerular capillaries | Details of glomerular capillaries: A narrative description of glomerular capillary changes. |
| Capillary wall thickening | Capillary wall thickening: A visual assessment of the capillary wall thickness. Choice of:
|
| Capillary wall duplication | Capillary wall duplication: A visual assessment of the presence of capillary wall duplication. Choice of:
|
| Mesangial cell interposition | Mesangial cell interposition: A visual assesment of the presence of interposed cells in the capillary periphery. Choice of:
|
| Capillary lumen | Capillary lumen: Description of changes in the capillary lumens. |
| Thrombi | Thrombi: Findings related to intracapillary thrombi. |
| Thrombi | Thrombi: Visual assessment of intracapillary thrombi. Choice of:
|
| Thrombus type | Thrombus type: Type of intracapillary thrombi.
|
| Endocapillary hypercellularity | Endocapillary hypercellularity: Findings related to endocapillary cellularity. |
| Endocapillary hypercellularity | Endocapillary hypercellularity: Visual assessment of endocapillary hypercellularity. Choice of:
|
| Cell type | Cell type: Composition of intracapillary cells. Choice of:
|
| Podocytes | Podocytes: Description of podocyte changes. |
| No abnormality detected | No abnormality detected: Statement that no abnormality was detected on examination of podocytes. |
| Details of podocytes | Details of podocytes: A narrative description of podocyte changes. |
| Hypertrophy | Hypertrophy: Enlarged podocytes often with amphophil cytoplasm. Choice of:
|
| Bi- or multinucleated podocytes | Bi- or multinucleated podocytes: Podocytes with 2 or more nuclei.
Assumed value: Absent |
| Resorption droplets | Resorption droplets: Podocytes with PAS positive resorption droplets.
|
| Pseudocysts | Pseudocysts: Podocytes with pseudocysts.
|
| Details of specific glomerular changes | Details of specific glomerular changes: Slot for detailed description of specific glomerular changes.
Include:
openEHR-EHR-CLUSTER.glomerulus_segmental_glomerulosclerosis_classification.v1. Include: All not explicitly excluded archetypes |
| Description of glomeruli | Description of glomeruli: A narrative description of glomerular findings, e.g. mesangial and endocapillary cellularity, capillary wall changes, podocytes, Bowman's space. For structured description of specific renal diseases use appropriate cluster (IgA nephropathy, lupus nephritis). |
| Tubules | Tubules: Description of tubular changes. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in renal tubules. |
| Tubular epithelial cell changes | Tubular epithelial cell changes: Description of tubular epithelial cell changes. Multiple choices possible.
|
| Casts in tubules | Casts in tubules: Choose the type of casts present in tubuli. Multiple choices possible.
|
| Tubular casts | Tubular casts: Structured report of kind of tubular casts present. |
| Tamm Horsfall protein | Tamm Horsfall protein: Presence of intratubular Tamm Horsfall protein. |
| Hyaline casts | Hyaline casts: Presence of hyalin casts in tubular lumen. |
| Granular casts | Granular casts: Presence of granular casts in tubular lumen. |
| Detached cells | Detached cells: Detached cells, commonly epithelial cells, present in the tubular lumen. |
| Red blood cells | Red blood cells: Collections of red blood cells or red blood cell casts present in tubular lumen. |
| Granulocytes | Granulocytes: Presence of neutrophil granulocytes in tubular lumen. |
| Mixed casts | Mixed casts: Casts consisting of more than one component. |
| Pigmented casts | Pigmented casts: Discolorated casts e.g. due to hemoglobin, myoglobin, drug pigments, bilirubin, melanin. |
| Myeloma casts | Myeloma casts: Characteristic myeloma casts, often surrounded by reactive tubular epithelial cells. or multinucleated cells, present in tubular lumen. |
| Crystals | Crystals: Crystals present in tubular lumen. |
| Tubular atrophy | Tubular atrophy: Semiquantitative or quantitative assessment of tubular atrophy. |
| Tubular atrophy semiquantitative | Tubular atrophy semiquantitative: Semiquantitative visual assessment of tubular atrophy.
|
| Tubules description | Tubules description: Desription of tubular changes, e.g. hyalin droplet change, acute epithelial damage, cytoplasmic vacuolation, sloughing of cells, loss of brush border. |
| Interstitium | Interstitium: Interstitial changes, especially semiquantitative or quantitative assessment of interstitial fibrosis. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal interstitium. |
| Quantification of interstitial fibrosis | Quantification of interstitial fibrosis: Quantification of interstitial fibrosis by image analysis methods. |
| Image analysis details | Image analysis details: To record details of the image analysis, e.g. software, algorithm. Include: All not explicitly excluded archetypes |
| Technique | Technique: Technique used to quantify fibrosis. Choice of:
|
| Percentage interstitial fibrosis | Percentage interstitial fibrosis: Percentage of the renal cortical tissue involved by fibrosis. Property: Proportion Units: % |
| Multimedia representation of image analysis | Multimedia representation of image analysis: Images, graphs and tables from automatic image analysis of interstitial fibrosis. |
| Cortical area with fibrosis estimated | Cortical area with fibrosis estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of abnormal cortical tissue with fibrosis. Property: Proportion Units: <=0.0 % Limit decimal places: 0 |
| Fibrous tissue estimated | Fibrous tissue estimated: Visual quantification of interstitial fibrosis; The fibrosis percentage is the percentage of all cortical tissue (excluding tubules and glomeruli) occupied by fibrous tissue. Property: Proportion Units: % Limit decimal places: 0 |
| Interstitium description | Interstitium description: Description of interstitial changes, e.g. edema, inflammatory cells, deposits. |
| Vasculature | Vasculature: Changes affecting arteries, arterioles, venes and peritubular capillaries. |
| No abnormality detected | No abnormality detected: A statement that no abnormality was detected in the renal vasculature. |
| Number of arteries | Number of arteries: Number of arteries in a renal biopsy. |
| Arteriosclerosis | Arteriosclerosis: Amount of arteriosclerosis in the most affected vessel. Choice of:
|
| Arteriolosclerosis | Arteriolosclerosis: Amount of arteriolosclerosis in the most affected vessel. Choice of:
|
| Vasculature description | Vasculature description: Description of vascular changes, e.g. vasculitis, venulitis. For description of severity of arteriosclerosis and arteriolosclerosis use coded text. |
| Amyloid | Amyloid: Findings related to amyloid deposition. |
| Amyloid not detected | Amyloid not detected: A statement that no amyloid deposition was detected. |
| Details of amyloid deposition | Details of amyloid deposition : Slot for detailed description of specific glomerular changes.
Include:
openEHR-EHR-CLUSTER.amyloid_deposition.v1 Include: All not explicitly excluded archetypes |
| Specific clinical situations | Specific clinical situations: Detailed structured description for specific clinical situations, e.g. biopsy of renal transplant, lupus nephritis, IgA nephropathy. Include: All not explicitly excluded archetypes |
| Multimedia representation | Multimedia representation: Images from lesions could be attached here. |
| Other contributors | |
| Translators |